 | • レポートコード：MRC23Q36833 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の心臓血管心膜パッチ市場について調査・分析し、世界の心臓血管心膜パッチ市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（自己組織、異種移植、合成）、用途別セグメント分析（病院、診療所、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Edwards Lifesciences Corporation、Visionary Medtech Solutions、Abbott、CryoLife, Inc.、Neovasc Inc.、FOC Medical、Baxter、Collagen Solutions、Labcor、RTI Surgical、WL Gore & Associates、LeMaitre Vascular, Inc.などが含まれています。 世界の心臓血管心膜パッチ市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、心臓血管心膜パッチ市場規模を推定する際に考慮しました。本レポートは、心臓血管心膜パッチの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、心臓血管心膜パッチに関するビジネス上の意思決定に役立てることを目的としています。 ・心臓血管心膜パッチ市場の概要 - 製品の定義 - 心臓血管心膜パッチのタイプ別セグメント - 世界の心臓血管心膜パッチ市場規模：タイプ別分析（自己組織、異種移植、合成） - 心臓血管心膜パッチの用途別セグメント - 世界の心臓血管心膜パッチ市場規模：用途別分析（病院、診療所、その他） - 世界の心臓血管心膜パッチ市場規模予測（2018年-2029年） - 心臓血管心膜パッチの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 心臓血管心膜パッチ市場の競争状況およびトレンド ・心臓血管心膜パッチの地域別市場規模 - 北米の心臓血管心膜パッチ市場規模（2018年-2029年） - アメリカの心臓血管心膜パッチ市場規模（2018年-2029年） - ヨーロッパの心臓血管心膜パッチ市場規模（2018年-2029年） - アジア太平洋の心臓血管心膜パッチ市場規模（2018年-2029年） - 中国の心臓血管心膜パッチ市場規模（2018年-2029年） - 日本の心臓血管心膜パッチ市場規模（2018年-2029年） - 韓国の心臓血管心膜パッチ市場規模（2018年-2029年） - インドの心臓血管心膜パッチ市場規模（2018年-2029年） - オーストラリアの心臓血管心膜パッチ市場規模（2018年-2029年） - 中南米の心臓血管心膜パッチ市場規模（2018年-2029年） - 中東・アフリカの心臓血管心膜パッチ市場規模（2018年-2029年） ・タイプ別セグメント：自己組織、異種移植、合成 - 世界の心臓血管心膜パッチのタイプ別販売量（2018年-2023年） - 世界の心臓血管心膜パッチのタイプ別売上（2018年-2023年） - 世界の心臓血管心膜パッチのタイプ別価格 ・用途別セグメント：病院、診療所、その他 - 世界の心臓血管心膜パッチの用途別販売量（2018年-2023年） - 世界の心臓血管心膜パッチの用途別売上（2018年-2023年） - 世界の心臓血管心膜パッチの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Edwards Lifesciences Corporation、Visionary Medtech Solutions、Abbott、CryoLife, Inc.、Neovasc Inc.、FOC Medical、Baxter、Collagen Solutions、Labcor、RTI Surgical、WL Gore & Associates、LeMaitre Vascular, Inc. ・産業チェーンと販売チャネルの分析 - 心臓血管心膜パッチ産業チェーン分析 - 心臓血管心膜パッチの主要原材料 - 心臓血管心膜パッチの販売チャネル - 心臓血管心膜パッチのディストリビューター - 心臓血管心膜パッチの主要顧客 ・心臓血管心膜パッチ市場ダイナミクス - 心臓血管心膜パッチの業界動向 - 心臓血管心膜パッチ市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Cardiovascular Pericardial Patch market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Cardiovascular Pericardial Patch is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cardiovascular Pericardial Patch is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Cardiovascular Pericardial Patch include Edwards Lifesciences Corporation, Visionary Medtech Solutions, Abbott, CryoLife, Inc., Neovasc Inc., FOC Medical, Baxter, Collagen Solutions and Labcor, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cardiovascular Pericardial Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular Pericardial Patch.
The Cardiovascular Pericardial Patch market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cardiovascular Pericardial Patch market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiovascular Pericardial Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Edwards Lifesciences Corporation
Visionary Medtech Solutions
Abbott
CryoLife, Inc.
Neovasc Inc.
FOC Medical
Baxter
Collagen Solutions
Labcor
RTI Surgical
WL Gore & Associates
LeMaitre Vascular, Inc.
Segment by Type
Autologous
Xenograft
Synthetic
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiovascular Pericardial Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiovascular Pericardial Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Cardiovascular Pericardial Patch Market Overview
1.1 Product Overview and Scope of Cardiovascular Pericardial Patch
1.2 Cardiovascular Pericardial Patch Segment by Type
1.2.1 Global Cardiovascular Pericardial Patch Market Value Comparison by Type (2023-2029)
1.2.2 Autologous
1.2.3 Xenograft
1.2.4 Synthetic
1.3 Cardiovascular Pericardial Patch Segment by Application
1.3.1 Global Cardiovascular Pericardial Patch Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Cardiovascular Pericardial Patch Market Size Estimates and Forecasts
1.4.1 Global Cardiovascular Pericardial Patch Revenue 2018-2029
1.4.2 Global Cardiovascular Pericardial Patch Sales 2018-2029
1.4.3 Global Cardiovascular Pericardial Patch Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Cardiovascular Pericardial Patch Market Competition by Manufacturers
2.1 Global Cardiovascular Pericardial Patch Sales Market Share by Manufacturers (2018-2023)
2.2 Global Cardiovascular Pericardial Patch Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Cardiovascular Pericardial Patch Average Price by Manufacturers (2018-2023)
2.4 Global Cardiovascular Pericardial Patch Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Cardiovascular Pericardial Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiovascular Pericardial Patch, Product Type & Application
2.7 Cardiovascular Pericardial Patch Market Competitive Situation and Trends
2.7.1 Cardiovascular Pericardial Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cardiovascular Pericardial Patch Players Market Share by Revenue
2.7.3 Global Cardiovascular Pericardial Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cardiovascular Pericardial Patch Retrospective Market Scenario by Region
3.1 Global Cardiovascular Pericardial Patch Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Cardiovascular Pericardial Patch Global Cardiovascular Pericardial Patch Sales by Region: 2018-2029
3.2.1 Global Cardiovascular Pericardial Patch Sales by Region: 2018-2023
3.2.2 Global Cardiovascular Pericardial Patch Sales by Region: 2024-2029
3.3 Global Cardiovascular Pericardial Patch Global Cardiovascular Pericardial Patch Revenue by Region: 2018-2029
3.3.1 Global Cardiovascular Pericardial Patch Revenue by Region: 2018-2023
3.3.2 Global Cardiovascular Pericardial Patch Revenue by Region: 2024-2029
3.4 North America Cardiovascular Pericardial Patch Market Facts & Figures by Country
3.4.1 North America Cardiovascular Pericardial Patch Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Cardiovascular Pericardial Patch Sales by Country (2018-2029)
3.4.3 North America Cardiovascular Pericardial Patch Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cardiovascular Pericardial Patch Market Facts & Figures by Country
3.5.1 Europe Cardiovascular Pericardial Patch Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Cardiovascular Pericardial Patch Sales by Country (2018-2029)
3.5.3 Europe Cardiovascular Pericardial Patch Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiovascular Pericardial Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Cardiovascular Pericardial Patch Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Cardiovascular Pericardial Patch Sales by Country (2018-2029)
3.6.3 Asia Pacific Cardiovascular Pericardial Patch Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cardiovascular Pericardial Patch Market Facts & Figures by Country
3.7.1 Latin America Cardiovascular Pericardial Patch Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Cardiovascular Pericardial Patch Sales by Country (2018-2029)
3.7.3 Latin America Cardiovascular Pericardial Patch Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiovascular Pericardial Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiovascular Pericardial Patch Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Cardiovascular Pericardial Patch Sales by Country (2018-2029)
3.8.3 Middle East and Africa Cardiovascular Pericardial Patch Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cardiovascular Pericardial Patch Sales by Type (2018-2029)
4.1.1 Global Cardiovascular Pericardial Patch Sales by Type (2018-2023)
4.1.2 Global Cardiovascular Pericardial Patch Sales by Type (2024-2029)
4.1.3 Global Cardiovascular Pericardial Patch Sales Market Share by Type (2018-2029)
4.2 Global Cardiovascular Pericardial Patch Revenue by Type (2018-2029)
4.2.1 Global Cardiovascular Pericardial Patch Revenue by Type (2018-2023)
4.2.2 Global Cardiovascular Pericardial Patch Revenue by Type (2024-2029)
4.2.3 Global Cardiovascular Pericardial Patch Revenue Market Share by Type (2018-2029)
4.3 Global Cardiovascular Pericardial Patch Price by Type (2018-2029)
5 Segment by Application
5.1 Global Cardiovascular Pericardial Patch Sales by Application (2018-2029)
5.1.1 Global Cardiovascular Pericardial Patch Sales by Application (2018-2023)
5.1.2 Global Cardiovascular Pericardial Patch Sales by Application (2024-2029)
5.1.3 Global Cardiovascular Pericardial Patch Sales Market Share by Application (2018-2029)
5.2 Global Cardiovascular Pericardial Patch Revenue by Application (2018-2029)
5.2.1 Global Cardiovascular Pericardial Patch Revenue by Application (2018-2023)
5.2.2 Global Cardiovascular Pericardial Patch Revenue by Application (2024-2029)
5.2.3 Global Cardiovascular Pericardial Patch Revenue Market Share by Application (2018-2029)
5.3 Global Cardiovascular Pericardial Patch Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Edwards Lifesciences Corporation
6.1.1 Edwards Lifesciences Corporation Corporation Information
6.1.2 Edwards Lifesciences Corporation Description and Business Overview
6.1.3 Edwards Lifesciences Corporation Cardiovascular Pericardial Patch Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Edwards Lifesciences Corporation Cardiovascular Pericardial Patch Product Portfolio
6.1.5 Edwards Lifesciences Corporation Recent Developments/Updates
6.2 Visionary Medtech Solutions
6.2.1 Visionary Medtech Solutions Corporation Information
6.2.2 Visionary Medtech Solutions Description and Business Overview
6.2.3 Visionary Medtech Solutions Cardiovascular Pericardial Patch Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Visionary Medtech Solutions Cardiovascular Pericardial Patch Product Portfolio
6.2.5 Visionary Medtech Solutions Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Cardiovascular Pericardial Patch Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Cardiovascular Pericardial Patch Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 CryoLife, Inc.
6.4.1 CryoLife, Inc. Corporation Information
6.4.2 CryoLife, Inc. Description and Business Overview
6.4.3 CryoLife, Inc. Cardiovascular Pericardial Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CryoLife, Inc. Cardiovascular Pericardial Patch Product Portfolio
6.4.5 CryoLife, Inc. Recent Developments/Updates
6.5 Neovasc Inc.
6.5.1 Neovasc Inc. Corporation Information
6.5.2 Neovasc Inc. Description and Business Overview
6.5.3 Neovasc Inc. Cardiovascular Pericardial Patch Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Neovasc Inc. Cardiovascular Pericardial Patch Product Portfolio
6.5.5 Neovasc Inc. Recent Developments/Updates
6.6 FOC Medical
6.6.1 FOC Medical Corporation Information
6.6.2 FOC Medical Description and Business Overview
6.6.3 FOC Medical Cardiovascular Pericardial Patch Sales, Revenue and Gross Margin (2018-2023)
6.6.4 FOC Medical Cardiovascular Pericardial Patch Product Portfolio
6.6.5 FOC Medical Recent Developments/Updates
6.7 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Cardiovascular Pericardial Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Baxter Cardiovascular Pericardial Patch Product Portfolio
6.7.5 Baxter Recent Developments/Updates
6.8 Collagen Solutions
6.8.1 Collagen Solutions Corporation Information
6.8.2 Collagen Solutions Description and Business Overview
6.8.3 Collagen Solutions Cardiovascular Pericardial Patch Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Collagen Solutions Cardiovascular Pericardial Patch Product Portfolio
6.8.5 Collagen Solutions Recent Developments/Updates
6.9 Labcor
6.9.1 Labcor Corporation Information
6.9.2 Labcor Description and Business Overview
6.9.3 Labcor Cardiovascular Pericardial Patch Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Labcor Cardiovascular Pericardial Patch Product Portfolio
6.9.5 Labcor Recent Developments/Updates
6.10 RTI Surgical
6.10.1 RTI Surgical Corporation Information
6.10.2 RTI Surgical Description and Business Overview
6.10.3 RTI Surgical Cardiovascular Pericardial Patch Sales, Revenue and Gross Margin (2018-2023)
6.10.4 RTI Surgical Cardiovascular Pericardial Patch Product Portfolio
6.10.5 RTI Surgical Recent Developments/Updates
6.11 WL Gore & Associates
6.11.1 WL Gore & Associates Corporation Information
6.11.2 WL Gore & Associates Cardiovascular Pericardial Patch Description and Business Overview
6.11.3 WL Gore & Associates Cardiovascular Pericardial Patch Sales, Revenue and Gross Margin (2018-2023)
6.11.4 WL Gore & Associates Cardiovascular Pericardial Patch Product Portfolio
6.11.5 WL Gore & Associates Recent Developments/Updates
6.12 LeMaitre Vascular, Inc.
6.12.1 LeMaitre Vascular, Inc. Corporation Information
6.12.2 LeMaitre Vascular, Inc. Cardiovascular Pericardial Patch Description and Business Overview
6.12.3 LeMaitre Vascular, Inc. Cardiovascular Pericardial Patch Sales, Revenue and Gross Margin (2018-2023)
6.12.4 LeMaitre Vascular, Inc. Cardiovascular Pericardial Patch Product Portfolio
6.12.5 LeMaitre Vascular, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiovascular Pericardial Patch Industry Chain Analysis
7.2 Cardiovascular Pericardial Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiovascular Pericardial Patch Production Mode & Process
7.4 Cardiovascular Pericardial Patch Sales and Marketing
7.4.1 Cardiovascular Pericardial Patch Sales Channels
7.4.2 Cardiovascular Pericardial Patch Distributors
7.5 Cardiovascular Pericardial Patch Customers
8 Cardiovascular Pericardial Patch Market Dynamics
8.1 Cardiovascular Pericardial Patch Industry Trends
8.2 Cardiovascular Pericardial Patch Market Drivers
8.3 Cardiovascular Pericardial Patch Market Challenges
8.4 Cardiovascular Pericardial Patch Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer